Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Change in Acquisitions & Divestments (2016 - 2024)

Bio-Techne has reported Change in Acquisitions & Divestments over the past 16 years, most recently at $1.1 million for Q3 2024.

  • Quarterly results put Change in Acquisitions & Divestments at $1.1 million for Q3 2024, down 95.43% from a year ago — trailing twelve months through Jun 2025 was $1.1 million (down 96.14% YoY), and the annual figure for FY2025 was $1.1 million, down 96.14%.
  • Change in Acquisitions & Divestments for Q3 2024 was $1.1 million at Bio-Techne, down from $4.3 million in the prior quarter.
  • Over the last five years, Change in Acquisitions & Divestments for TECH hit a ceiling of $73.2 million in Q3 2022 and a floor of -$44.1 million in Q1 2023.
  • Median Change in Acquisitions & Divestments over the past 5 years was $14.1 million (2020), compared with a mean of $18.1 million.
  • Biggest five-year swings in Change in Acquisitions & Divestments: soared 488.1% in 2022 and later plummeted 423.84% in 2023.
  • Bio-Techne's Change in Acquisitions & Divestments stood at $14.1 million in 2020, then fell by 11.75% to $12.4 million in 2021, then soared by 488.1% to $73.2 million in 2022, then plummeted by 67.55% to $23.8 million in 2023, then tumbled by 95.43% to $1.1 million in 2024.
  • The last three reported values for Change in Acquisitions & Divestments were $1.1 million (Q3 2024), $4.3 million (Q2 2024), and $23.8 million (Q3 2023) per Business Quant data.